1629658-18-9 Usage
Uses
Used in Pharmaceutical Research:
(S)-2-((tert-butoxycarbonyl)amino)-3-(3-chloro-4-fluorophenyl)propanoic acid is used as a key intermediate in the synthesis of various pharmaceutical compounds due to its unique structural and chemical properties. Its chiral nature allows for the development of enantiomerically pure drugs, which can have significant implications in terms of efficacy and safety.
Used in Organic Synthesis:
In the field of organic synthesis, (S)-2-((tert-butoxycarbonyl)amino)-3-(3-chloro-4-fluorophenyl)propanoic acid serves as a versatile building block for the creation of more complex molecules. Its functional groups can be further modified or used as starting points for the synthesis of a wide range of organic compounds, including potential drug candidates.
Used in Drug Development:
The unique structural features of (S)-2-((tert-butoxycarbonyl)amino)-3-(3-chloro-4-fluorophenyl)propanoic acid make it a promising candidate for drug development. Its potential applications in this area include the development of novel therapeutic agents targeting various diseases and conditions, as well as the improvement of existing drugs through structural modifications.
Used in Chemical Research:
(S)-2-((tert-butoxycarbonyl)amino)-3-(3-chloro-4-fluorophenyl)propanoic acid is also utilized in chemical research to study the properties and reactivity of chiral molecules. This can lead to a better understanding of the relationship between molecular structure and biological activity, which is crucial for the design of new drugs and the optimization of existing ones.
Check Digit Verification of cas no
The CAS Registry Mumber 1629658-18-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,2,9,6,5 and 8 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1629658-18:
(9*1)+(8*6)+(7*2)+(6*9)+(5*6)+(4*5)+(3*8)+(2*1)+(1*8)=209
209 % 10 = 9
So 1629658-18-9 is a valid CAS Registry Number.
1629658-18-9Relevant academic research and scientific papers
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
-
Page/Page column 699; 700, (2016/05/09)
The present disclosure provides novel macrocyclic peptides which inhibit the PD-1/PD-L1 and PD-L1/CD80 protein/protein interaction, and thus are useful for the amelioration of various diseases, including cancer and infectious diseases.
